Research Article
Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer
Table 2
The median and positive rates of tumor markers in benign chest disease (BCD), lung adenocarcinoma (LAC), and lung squamous cell carcinoma (LSCC).
| | Parameters | BCD | LAC | LSCC | 1 value | 2 value | 3 value |
| | Median (ng/ml) | | | | | | | | CEA | 2.1 | 7.4 | 3.3 | 0.000 | 0.000 | 0.000 | | CA125 | 12.8 | 22.5 | 20.0 | 0.000 | 0.000 | 0.074 | | CA15-3 | 12.3 | 20.4 | 15.0 | 0.000 | 0.035 | 0.000 | | CA19-9 | 10.5 | 14.0 | 10.6 | 0.010 | 0.397 | 0.000 | | CA72-4 | 1.3 | 2.0 | 1.8 | 0.000 | 0.019 | 0.164 | | CYFRA21-1 | 2.3 | 4.1 | 7.6 | 0.000 | 0.000 | 0.000 | | SCC-Ag | 0.7 | 0.6 | 1.3 | 0.443 | 0.000 | 0.000 | | Positive rate (%) | | | | | | | | CEA | 7.8 | 61.8 | 23.5 | 0.000 | 0.001 | 0.000 | | CA125 | 8.7 | 40.6 | 28.9 | 0.000 | 0.000 | 0.009 | | CA15-3 | 2.9 | 30.2 | 9.0 | 0.000 | 0.051 | 0.000 | | CA19-9 | 5.8 | 19.8 | 5.4 | 0.001 | 0.888 | 0.000 | | CA72-4 | 11.7 | 21.7 | 16.9 | 0.022 | 0.242 | 0.190 | | CYFRA21-1 | 13.6 | 61.6 | 88.6 | 0.000 | 0.000 | 0.000 | | SCC-Ag | 3.9 | 8.5 | 39.8 | 0.113 | 0.000 | 0.000 |
|
|
1 value: BCD vs LAC, 2 value: BCD vs LSCC, 3 value: LAC vs LSCC. |
